CLINICAL_TRIALS
trial_result
· 2024-12-11
Clinical Trial Update: Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53) [Phase 3]
Summary
Phase 3 RACER53 trial results for Viltepso (viltolarsen) in ambulant boys with Duchenne Muscular Dystrophy have been posted, reporting efficacy and safety findi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NS Pharma, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: COMPLETED | Results posted: 2024-12-11